title: Deal watch: Pfizer and GSK join race for T cell cancer therapies.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Flemming
mesh_terms: D004345:Drug Industry; D005818:Genetic Engineering; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*